MARKET

THMO

THMO

Thermogenesis Holdings Inc
NASDAQ
0.1850
+0.0009
+0.49%
After Hours: 0.1900 +0.005 +2.70% 16:40 09/26 EDT
OPEN
0.1850
PREV CLOSE
0.1841
HIGH
0.1900
LOW
0.1810
VOLUME
62.30K
TURNOVER
0
52 WEEK HIGH
2.180
52 WEEK LOW
0.0900
MARKET CAP
5.79M
P/E (TTM)
-0.2545
1D
5D
1M
3M
1Y
5Y
Short Volatility Alert: ThermoGenesis Holdings, Inc.
On Friday, shares of ThermoGenesis Holdings, Inc. (NASDAQ: THMO) experienced volatile short activity. After the activity, the stock price went down -9.52% to $0.19. The overall sentiment for THMO has been Bearish.
Benzinga · 09/19 14:22
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Benzinga · 09/15 12:26
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.
Benzinga · 09/14 16:28
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Benzinga · 09/14 12:08
BRIEF-Thermogenesis Holdings- On Sept 7 Got Notice From Nasdaq Granting Additional 180 Calendar Daysto Regain Compliance With Minimum Bid Price Requirement
BRIEF-Thermogenesis Holdings- On Sept 7 Got Notice From Nasdaq Granting Additional 180 Calendar Daysto Regain Compliance With Minimum Bid Price Requirement
Reuters · 09/08 20:06
Looking Into ThermoGenesis Holdings's Return On Capital Employed
ThermoGenesis Holdings (NASDAQ:THMO) brought in sales totaling $3.03 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 37.57%, resulting in a loss of $2.80 million.
Benzinga · 09/07 13:53
ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview at the H.C. Wain...
PR Newswire · 09/07 12:30
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Investor Place · 09/07 11:27
More
About THMO
ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for chimeric antigen receptor- T (CAR-T) and other cell-based therapies. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for large scale cell manufacturing services. It manufactures and markets three categories of products, Clinical Bio-Banking Applications, Point-of-Care Applications, and Large Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications includes AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Point-of-Care Applications includes PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory useand CAR-TXpress Platform for clinical manufacturing.

Webull offers kinds of Thermogenesis Holdings Inc stock information, including NASDAQ:THMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, THMO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading THMO stock methods without spending real money on the virtual paper trading platform.